| scholarly article | Q13442814 |
| P2093 | author name string | Hong Zhao | |
| Qing Xu | |||
| Yong Gao | |||
| Li-Na Fu | |||
| Jie-Jun Wang | |||
| Geng-Jin Lin | |||
| Li-Ping Qian | |||
| San-Rong Xu | |||
| Xue-Liang Guo | |||
| P2860 | cites work | VEGF165 antisense RNA suppresses oncogenic properties of human esophageal squamous cell carcinoma | Q30724216 |
| Upregulation of vascular endothelial growth factor by hydrogen peroxide in human colon cancer | Q30724325 | ||
| Influence of hepatic arterial blockage on blood perfusion and VEGF, MMP-1 expression of implanted liver cancer in rats | Q33183761 | ||
| Phase I study of docetaxel dose escalation in combination with fixed weekly gemcitabine in patients with advanced malignancies | Q33504606 | ||
| Metastatic human hepatocellular carcinoma models in nude mice and cell line with metastatic potential | Q34512125 | ||
| The prognostic molecular markers in hepatocellular carcinoma | Q34668320 | ||
| Expression of interleukin-8 by human melanoma cells up-regulates MMP-2 activity and increases tumor growth and metastasis | Q35763932 | ||
| Relationship between the expression of iNOS,VEGF,tumor angiogenesis and gastric cancer | Q36308164 | ||
| TGF beta1 expression and angiogenesis in colorectal cancer tissue | Q36308557 | ||
| Expression of vascular endothelial growth factor and its role in oncogenesis of human gastric carcinoma | Q36397210 | ||
| Molecular mechanism about lymphogenous metastasis of hepatocarcinoma cells in mice. | Q36397228 | ||
| Reduction of tumorigenicity of SMMC-7721 hepatoma cells by vascular endothelial growth factor antisense gene therapy. | Q36397313 | ||
| Alterations in metastatic properties of hepatocellular carcinoma cell following H-ras oncogene transfection | Q36397376 | ||
| Effect of intestinal ischemia-reperfusion on expressions of endogenous basic fibroblast growth factor and transforming growth factor betain lung and its relation with lung repair | Q36397470 | ||
| Clinical implication of VEGF serum levels in cirrhotic patients with or without portal hypertension | Q36415546 | ||
| Expression of VEGF(121) in gastric carcinoma MGC803 cell line | Q36491934 | ||
| bFGF and TGFbeta expression in rat kidneys after ischemic/ reperfusional gut injury and its relationship with tissue repair | Q36492131 | ||
| Significance of vascular endothelial growth factor messenger RNA expression in gastric cancer | Q36620197 | ||
| Study of angiogenesis induced by metastatic and non-metastatic liver cancer by corneal micropocket model in nude mice | Q39592414 | ||
| Taxotere resistance in SUIT Taxotere resistance in pancreatic carcinoma cell line SUIT 2 and its sublines. | Q40749621 | ||
| Effects of Taxotere on invasive potential and multidrug resistance phenotype in pancreatic carcinoma cell line SUIT-2 | Q40753744 | ||
| Effects of hypoxia, hyperoxia on the regulation of expression and activity of matrix metalloproteinase-2 in hepatic stellate cells | Q41513925 | ||
| Paclitaxel (Taxol): an inhibitor of angiogenesis in a highly vascularized transgenic breast cancer | Q41740928 | ||
| Recurrence or metastasis of HCC:predictors, early detection and experimental antiangiogenic therapy | Q42102126 | ||
| Taxol blocks processes essential for prostate tumor cell (PC-3 ML) invasion and metastases | Q42804762 | ||
| The antiangiogenic property of docetaxel is synergistic with a recombinant humanized monoclonal antibody against vascular endothelial growth factor or 2-methoxyestradiol but antagonized by endothelial growth factors | Q43579728 | ||
| Inhibition of growth factor production and angiogenesis in human cancer cells by ZD1839 (Iressa), a selective epidermal growth factor receptor tyrosine kinase inhibitor. | Q43606283 | ||
| Docetaxel versus paclitaxel for antiangiogenesis | Q43887955 | ||
| Anti-Vascular endothelial growth factor treatment augments tumor radiation response under normoxic or hypoxic conditions. | Q54033425 | ||
| 8-Chloro-cyclic AMP inhibits autocrine and angiogenic growth factor production in human colorectal and breast cancer | Q57424727 | ||
| The microtubule-affecting drug paclitaxel has antiangiogenic activity | Q60043754 | ||
| Inhibition of angiogenesis and breast cancer in mice by the microtubule inhibitors 2-methoxyestradiol and taxol | Q71955574 | ||
| Phase I and pharmacologic study of paclitaxel administered weekly in patients with relapsed ovarian cancer | Q71975333 | ||
| Inhibition of invasion and lymph node metastasis of gastrointestinal cancer cells by R-94138, a matrix metalloproteinase inhibitor | Q73505451 | ||
| Vegf, Vegf-B, Vegf-C and their receptors KDR, FLT-1 and FLT-4 during the neoplastic progression of human colonic mucosa | Q73595171 | ||
| Implication of vascular endothelial growth factor and p53 status for angiogenesis in noninvasive colorectal carcinoma | Q73666498 | ||
| Prognostic value of vascular endothelial growth factor expression in colorectal cancer patients | Q73670868 | ||
| [Inhibition of tumor neo-angiogenesis and induction of apoptosis as properties of docetaxel (taxotere)] | Q78209972 | ||
| P433 | issue | 9 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | docetaxel | Q420436 |
| P304 | page(s) | 1995-1998 | |
| P577 | publication date | 2003-09-01 | |
| P1433 | published in | World Journal of Gastroenterology | Q15708885 |
| P1476 | title | Inhibitory effects of docetaxel on expression of VEGF, bFGF and MMPs of LS174T cell | |
| P478 | volume | 9 |
| Q36308321 | Adeno-associated virus mediated endostatin gene therapy in combination with topoisomerase inhibitor effectively controls liver tumor in mouse model |
| Q60922888 | Anti-Mucin1 Aptamer-Conjugated Chitosan Nanoparticles for Targeted Co-Delivery of Docetaxel and IGF-1R siRNA to SKBR3 Metastatic Breast Cancer Cells |
| Q37337814 | Antiangiogenic cancer treatment: The great discovery and greater complexity (Review). |
| Q51298069 | Chemotherapy and radiation regimens to breast cancer treatment induce changes in mRNA levels of renin-angiotensin system related genes in cardiac tissue. |
| Q42948386 | Effects of recombinant human endostatin and docetaxel on MMP and its following anti-neoplastic effect under different administration sequences |
| Q46787048 | How reliable is MRI for predicting extent of residual breast cancer with different primary medical therapies? |
| Q36661727 | Nab-paclitaxel efficacy in the orthotopic model of human breast cancer is significantly enhanced by concurrent anti-vascular endothelial growth factor A therapy |
| Q46561936 | Sonographic evaluation of early-stage breast cancers that undergo neoadjuvant chemotherapy |
| Q39773632 | Targeted drug and gene delivery systems for lung cancer therapy |
| Q36929559 | VEGF signaling inhibitors: more pro-apoptotic than anti-angiogenic |
Search more.